Fumihiko Matsumoto

Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation <i>In Vivo</i> and <i>In Vitro</i>

Daisuke Sano, Fumihiko Matsumoto, David R. Valdecanas et al. · Clinical Cancer Research · 2011 · 75 citations · Full text

Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis

Shinichi Ohba, Hiroaki Fujii, Shin Ito et al. · Journal of Oral Pathology and Medicine · 2009 · 52 citations

A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe

Oliver Riesterer, Fumihiko Matsumoto, Li Wang et al. · Investigational New Drugs · 2009 · 50 citations

Cancer Research, Oncology, Novel Chk Inhibitor +10

Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults

Kazuhiko Horiguchi, Yusaku Yoshida, Kenji Iwaku et al. · Endocrine Journal · 2021 · 50 citations · Full text

Surgical Oncology, Health Sciences, Position Paper +14

A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis

Fumihiko Matsumoto, Hiroaki Fujii, Masaaki Abe et al. · Human Pathology · 2006 · 46 citations

Thyroid Tumors, Medicine, Thyroid Disease +8